Sign in
Back
Intravenous GPIIb/IIIa Inhibitor for Secondary Prevention of Shunt Thrombosis in a Pediatric Patient
Journal article   Peer reviewed

Intravenous GPIIb/IIIa Inhibitor for Secondary Prevention of Shunt Thrombosis in a Pediatric Patient

Sirisha Emani, Aditya K Kaza, Melvin Almodovar, Ravi Thiagarajan and Sitaram M Emani
The Annals of thoracic surgery, Vol.99(6), pp.e151-e153
2015-06
DOI: https://doi.org/10.1016/j.athoracsur.2015.02.103
PMID: 26046909

Abstract

Anastomosis, Surgical - adverse effects Aorta, Thoracic - diagnostic imaging Aorta, Thoracic - surgery Female Humans Infant Infusions, Intravenous Platelet Glycoprotein GPIIb-IIIa Complex - administration & dosage Postoperative Complications - prevention & control Pulmonary Artery - diagnostic imaging Pulmonary Artery - surgery Radiography Secondary Prevention - methods Thrombosis - diagnosis Thrombosis - etiology Thrombosis - prevention & control
Thrombosis occurs after aortopulmonary shunting in children despite the use of heparin and oral antiplatelet agents. We describe the use of an intravenous antiplatelet agent for secondary prevention of shunt thrombosis without adverse events. Platelet mapping was used to monitor the effects and demonstrated the rapid onset of platelet inhibition.

Metrics

1 Record Views
6 Times Cited - Web of Science

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics
1 Clinical & Life Sciences
1.71 Cardiology - Circulation
1.71.193 Acute Myocardial Infarction
Web Of Science research areas
Cardiac & Cardiovascular Systems
Respiratory System
Surgery
ESI research areas
Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details